SEC to discuss India’s first indigenously developed vaccine against cervical cancer

The first indigenously developed quadrivalent human papillomavirus (qHPV) vaccine against cervical cancer by the Serum Institute of India (SII) will be discussed by the Subject expert committee on Wednesday. The application for market authorization of the qHPV vaccine was submitted to the DCGI on June 8 by Prakash Kumar Singh […]